PR92487

PLYMOUTH MEETING, Pa., Oct. 25, 2021 /PRNewswire=KYODO JBN/ --

- International collaboration publishes first of several evidence-based expert

consensus guidelines with latest cancer treatment recommendations, beginning

with cervical cancer.

The National Comprehensive Cancer Network(R) (NCCN(R) -

https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=2114089472&u=https%3A%2F%2Fwww.nccn.org%2F&a=NCCN)—an alliance of leading cancer centers (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=1322745865&u=https%3A%2F%2Fwww.nccn.org%2Fhome%2Fmember-institutions&a=leading+cancer+centers) in the United States—today announced the publication of new NCCN

Guidelines(R) for Cervical Cancer: Poland Edition. This is the organization's

most-recent collaboration to advance global cancer care (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=2261996716&u=https%3A%2F%2Fwww.nccn.org%2Fglobal%2Fwhat-we-do&a=global+cancer+care) through recommendations based on the latest evidence and expert consensus.

NCCN also works on regional guidelines adaptations, translations, and

harmonizations with local providers across Sub-Saharan Africa, the Middle East

and North Africa (MENA), the Caribbean, and other countries in Asia, Europe,

and South America.

Photo - https://mma.prnewswire.com/media/1666371/NCCNCervicalPolandCover.jpg

Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg

"It's easier to predict cancer care needs when we work together to standardize

care on an international scale—carefully adjusted for unique regional

variations—improving quality while controlling costs," said Robert W. Carlson,

MD, CEO, NCCN. "Everyone worldwide should benefit from our rapidly expanding

knowledge on how to treat cancer most effectively. This goes both ways; when we

work with experts around the globe we learn valuable lessons for improving

cancer care in the United States."

The NCCN Guidelines(R) for Cervical Cancer: Poland Edition are a pilot project

through a collaboration organized by Maria Sklodowska-Curie National Research

Institute (MSCNRIO), Alliance for Innovation (AFI), and NCCN. The project is

led by Polish oncologists and includes the Health Technology Assessment Agency,

National Health Fund, Ministry of Health representatives, and Polish patient

advocacy groups.

There are plans to expand the NCCN Guidelines: Poland Editions to eventually

cover the majority of incident cancer cases in Poland. The next NCCN Guidelines

to be adapted are:

    -- central nervous system cancers;

    -- uterine neoplasms;

    -- and ovarian cancer.

NCCN Guidelines are the recognized standard for clinical direction and policy

in cancer management and the most thorough and frequently-updated clinical

practice guidelines available in any area of medicine. They are widely used and

well-regarded by cancer care providers around the world as noted in recent

independent, peer-reviewed studies out of Nigeria (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=2758748814&u=https%3A%2F%2Fecancer.org%2Fen%2Fjournal%2Farticle%2F1294-assessment-of-guideline-adherence-in-breast-cancer-management-among-oncologists-in-nigeria%2Fabstract&a=Nigeria), Italy (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=1936104002&u=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F34519689%2F&a=Italy), and China (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=1406446802&u=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F33626607%2F&a=China).

View International Adaptations and Translations of NCCN Guidelines at

NCCN.org/global (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=6813426&u=https%3A%2F%2Fwww.nccn.org%2Fglobal%2Fwhat-we-do&a=NCCN.org%2Fglobal) and join the conversation with #NCCNGlobal (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=476707594&u=https%3A%2F%2Ftwitter.com%2Fsearch%3Fq%3D%2523NCCNglobal%26src%3Dtyped_query%26f%3Dlive&a=%23NCCNGlobal).

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network(R) (NCCN(R) -

https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=3123837351&u=http%3A%2F%2Fwww.nccn.org%2F&a=NCCN) is a not-for-profit alliance of leading cancer centers (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=1022832203&u=https%3A%2F%2Fwww.nccn.org%2Fmembers%2Fnetwork.aspx&a=leading+cancer+centers) devoted to patient care, research, and education. NCCN is dedicated to

improving and facilitating quality, effective, efficient, and accessible cancer

care so patients can live better lives. The NCCN Clinical Practice Guidelines

in Oncology (NCCN Guidelines(R) -

https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=2431191575&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fdefault.aspx&a=NCCN+Guidelines) provide transparent, evidence-based, expert consensus recommendations for

cancer treatment, prevention, and supportive services; they are the recognized

standard for clinical direction and policy in cancer management and the most

thorough and frequently-updated clinical practice guidelines available in any

area of medicine. The NCCN Guidelines for Patients(R) (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=282771409&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Fguidelines%2Fcancers.aspx&a=NCCN+Guidelines+for+Patients) provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation(R) (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=251199318&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Fwaystogive%2Fdefault.aspx&a=NCCN+Foundation). NCCN also advances continuing education (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=2702395678&u=https%3A%2F%2Feducation.nccn.org%2F&a=continuing+education), global initiatives (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=2201818491&u=https%3A%2F%2Fwww.nccn.org%2Fglobal%2Fdefault.aspx&a=global+initiatives), policy (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=1862250616&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fmeetings%2Foncology_policy_program%2Fdefault.aspx&a=policy), and research collaboration (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=340784013&u=https%3A%2F%2Fwww.nccn.org%2Fclinical_trials%2Fclinicians.aspx&a=collaboration) and publication (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=3587136478&u=https%3A%2F%2Fwww.nccn.org%2Fjnccn%2F&a=publication) in oncology. Visit NCCN.org (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=1371821736&u=http%3A%2F%2Fwww.nccn.org%2F&a=NCCN.org) for more information and follow NCCN on Facebook @NCCNorg (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=2648065331&u=http%3A%2F%2Fwww.facebook.com%2FNCCNorg&a=%40NCCNorg), Instagram @NCCNorg (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=1026432743&u=https%3A%2F%2Fwww.instagram.com%2Fnccnorg%2F&a=%40NCCNorg), and Twitter @NCCN (https://c212.net/c/link/?t=0&l=en&o=3330167-1&h=1096830161&u=http%3A%2F%2Fwww.twitter.com%2Fnccn&a=%40NCCN).

Media Contact:

Rachel Darwin

267-622-6624

darwin@nccn.org

SOURCE   National Comprehensive Cancer Network